FindTrial
Sign In

The multi-center study of the application of ABUS in the Diagnosis of Breast Cancer

The multi-center study of the application of ABUS in the Diagnosis of Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017908
Enrollment
Unknown
Registered
2018-08-21
Start date
2016-02-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Magnetic Resonance Imaging(MRI) and Pathology
Index test:Hand-held&#32
ultrasound,&#32
Invenia&#32
ABUS,&#32
mammography

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 69 Years

Inclusion criteria

Inclusion criteria: 1. Woman aged 30 to 69 yrs old; 2. Woman who visits the doctor for the first time for breast cancer; 3. No visible suspicious signs of breast cancer.

Exclusion criteria

Exclusion criteria: 1. Pregnant, breast feeding or planning to become pregnant; 2. History of lumpectomy, contralateral mastectomy, breast augmentation; 3. Surgical or percutaneous biopsy in the last 12 months; 4. Diagnosis or treatment for cancer in the last 12 months; 5. Suspicious signs of breast cancer.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;Flase Positive Rate;Flase Negative Rate;—

Countries

China

Contacts

Public ContactYoulin Qiao

Cancer Hospital, Chinese Academy of Medical Sciences

qiaoy@cicams.ac.cn+86 010 8778 8489

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026